Chad J. Kolean - Jan 17, 2023 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Christina Blakley, Attorney in-fact for Chad J. Kolean
Stock symbol
CLRB
Transactions as of
Jan 17, 2023
Transactions value $
$0
Form type
4
Date filed
1/18/2023, 05:33 PM
Previous filing
Apr 15, 2022
Next filing
Dec 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +104K $0.00 104K Jan 17, 2023 Common Stock 104K $1.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.